A Visionary Roadmap for Clinicians and Patients, ‘Rebooting Cancer Care’ Explores How Advanced Technology Can Restore ...

Conferences can be an excellent way to connect with fellow oncologists and stay informed on the latest research. These events are key to providing ...

On January 12, NP-G2-044 (Prilukae), a novel oral fascin inhibitor earned ODD for the treatment of pancreatic cancer. This designation covers the use of the agent as monotherapy and in combination ...

An introduction to the 2026 Oncology Nurse Advisor Summit and links to review the agenda and register to attend this year’s virtual event.

Creative Biolabs is accelerating CAR‑T innovation, driving breakthroughs in solid tumor targeting. SHIRLEY, NY, UNITED ...

Coherus Oncology (CHRS) has priced an underwritten public offering of 28.6M shares at $1.75 per share. The company expects to ...

Survivorship is a relational shift for the whole family, not a return to pre-cancer life. Fear of recurrence affects the ...

Brain metastases are far from a niche concern; with 100,000 to 200,000 cases diagnosed annually in the US, the scale of the ...

The earnings results for Citius Oncology (NASDAQ: CTOR) for Q1 were made public on Friday, February 13, 2026 at 04:00 PM. Here's a comprehensive overview of the announcement. Citius Oncology missed ...

Tuesday, Feb. 3, is the 11th annual National Women Physicians Day — a day that honors female physicians breaking barriers in ...

Company reports $3.9 million in revenue generated from initial sales in December 2025 and provides first fiscal quarter 2026 financial results CRANFORD, N.J., Feb.

The Bank of Cyprus Oncology Center is moving forward with major expansion plans, including new operating theatres, a €4.5 million PET/CT scanner and a new branch in Larnaca, but has warned that ...